Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Baminercept (BG9924) in Rheumatoid Arthritis
NCT00523328Phase 2Terminated
- Sponsor
- Biogen
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 2 trial of baminercept in rheumatoid arthritis (RA), sponsored by Biogen. Started Aug 2007; status: terminated.
02
Drugs
baminercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00523328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523328.